Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage

SUMMARY: We compared the patterns of osteoporosis medication prescribing between two provinces in Canada with different public drug coverage policies. Oral bisphosphonates were the primary drugs used, yet access to the second-generation oral bisphosphonates (alendronate, risedronate) was limited in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadarette, S. M., Carney, G., Baek, D., Gunraj, N., Paterson, J. M., Dormuth, C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304053/
https://www.ncbi.nlm.nih.gov/pubmed/21901476
http://dx.doi.org/10.1007/s00198-011-1771-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304053/
https://www.ncbi.nlm.nih.gov/pubmed/21901476
http://dx.doi.org/10.1007/s00198-011-1771-2

Ejemplares similares